Continuum Advisory’s Nutrien NTR Stock Holding History

Continuum Advisory’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16	Closed	-$795	–	1176
2025 Q1	$795	Buy	+16	New	+$819	﹤0.01%	1539

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

SII

Silchester International Investors London, United Kingdom $62M AUM 14.06% 1-Year Est. Return

Continuum Advisory's NTR Position: Q2 2025 in Review

Continuum Advisory sold out of Nutrien (NTR) in Q2 2025, closing a stake of 16 shares — an estimated $795 sold.

Continuum Advisory first reported a position in NTR in Q1 2025 and held it in 1 quarter. The position peaked at $795 in Q1 2025. 648 funds tracked by Wall St. Rank hold NTR as of Q2 2025.

Continuum Advisory reported no remaining Nutrien position as of Q2 2025 after selling out during the quarter.
Continuum Advisory sold 16 Nutrien shares in Q2 2025, an estimated $795.
Continuum Advisory first reported a position in Nutrien in Q1 2025 and held it in 1 quarter.
Continuum Advisory's Nutrien position peaked at $795 in Q1 2025.
648 funds tracked by Wall St. Rank held Nutrien as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.